Integration of Computational and Biological Analysis of Serotonin Transporters
血清素转运蛋白的计算和生物学分析的整合
基本信息
- 批准号:7657276
- 负责人:
- 金额:$ 13.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAminobutyric AcidsAntidepressive AgentsAnxiety DisordersAreaAutistic DisorderBindingBinding SitesBiochemicalBiochemistryBiologicalBiologyChemicalsClinicalCocaineComplexComputational BiologyComputer SimulationDataDevelopmentDiseaseDockingDopamineDrosophila genusDrug Delivery SystemsEnvironmentEvolutionExperimental ModelsFamilyFamily memberFutureGenesGlycineHomologous GeneHumanIndividualIntegral Membrane ProteinInvestigationIonsLaboratoriesLeucineLigandsLinkMajor Depressive DisorderMembraneMembrane ProteinsMental HealthMental disordersMethodologyMethodsModelingModificationMolecularMood DisordersMovementMutagenesisMutationNervous system structureNeurologicNeuronsNorepinephrineObsessive-Compulsive DisorderPatternPharmaceutical PreparationsPharmacologyPlayPost-Traumatic Stress DisordersPrincipal InvestigatorProcessPropertyProteinsResearchResearch PersonnelResolutionRoleSamplingSequence AlignmentSerotoninSideSignal TransductionStressStructural ModelsStructureSubstrate SpecificitySynaptic VesiclesTestingTherapeuticTherapeutic AgentsTrainingTricyclic Antidepressive AgentsTryptaminesUncertaintyUnited States National Institutes of HealthUniversitiesValidationVariantVertebral columnaddictionbaseclinically relevantclub drugcomparativecomputer studiesdepressiondopamine transporterdrug of abuseecstasyextracellularinhibitor/antagonistinsightinstructorknowledge basemethod developmentmolecular dynamicsmonoaminemutantneuropsychiatryneurotransmitter releasepoly(L-glutamic acid(60)-L-alanine(30)-L-tyrosine(10))presynapticprogramsprotein foldingreuptakeserotonin transportersmall moleculesolutesymporteruptake
项目摘要
DESCRIPTION (provided by applicant): The purpose of this project is to utilize current experimental data to construct a relevant comparative structural model of the serotonin transporter (SERT) based on a recently crystallized bacterial family member. Recent advancements in computation protein folding have legitimized its use in modeling integral membrane proteins. The principal investigator, who has obtained a strong background in the study of structural aspects of SERT using biochemistry and pharmacology in the laboratory of Dr. Randy Blakely who has an outstanding research record in this area, will pursue training in the area of computational biology with a talented researcher, Dr. Jens Meiler, who has played an intergral role in development of methods to analyze protein-small molecule interaction in silico. This project with its heavy emphasis on computational modeling represents a new direction in research for the P.I. who to date has focused on molecular/biochemical study of membrane proteins. Vanderbilt University offers a superior environment for computational studies through the NIH supported ACCRE processor cluster and multiple genes formally expressed in membrane protein modeling (Lybrand, Chazin). This training will allow Dr. Henry to build, test and refine models of SERT interactions with its substrate serotonin and the club drug MDMA. These studies have the potential to provide significant insight into the structural components necessary for recognition and movement of sertonin and drugs of abuse through the transporter. Furthermore, this training will allow Dr. Henry to apply these methods to future projects and broaden his knowledge base as an academic instructor/investigator. Relevance: The serotonin transporter is arguably the most clinically relevant protein today. It is the major target of antidepressants and several drugs of abuse and has been linked to several psychological disorders including: depression, obsessive-compulsive disorder, post-traumatic stress disorder and more recently to aspects of autism. However, we still do not understand many of the details of how SERT recognizes and moves substrates like serotonin and MDMA into the nerve cell. Understanding these aspects of such an important process in the nervous system could have an important impact on clinical targeting of SERT as well as the related norepinepherine and dopamine transporters all which play critical roles in our neurological and psychological health.
描述(由申请人提供):该项目的目的是利用当前的实验数据,基于最近结晶的细菌家族成员构建血清素转运蛋白(SERT)的相关比较结构模型。计算蛋白质折叠的最新进展使其在完整膜蛋白建模中的使用合法化。首席研究员在 Randy Blakely 博士的实验室中利用生物化学和药理学研究 SERT 的结构方面获得了强大的背景,Randy Blakely 博士在该领域拥有出色的研究记录,他将与才华横溢的研究员 Jens Meiler 博士一起接受计算生物学领域的培训,Jens Meiler 博士在计算机分析蛋白质-小分子相互作用的方法开发中发挥了重要作用。该项目非常重视计算建模,代表了 P.I. 的研究新方向。迄今为止,谁专注于膜蛋白的分子/生化研究。范德比尔特大学通过 NIH 支持的 ACCRE 处理器集群和在膜蛋白模型中正式表达的多个基因(Lybrand、Chazin)为计算研究提供了优越的环境。该培训将使 Henry 博士能够建立、测试和完善 SERT 与其底物血清素和俱乐部药物 MDMA 相互作用的模型。这些研究有可能对通过转运蛋白识别和移动血清素和滥用药物所需的结构成分提供重要的见解。此外,这次培训将使亨利博士能够将这些方法应用到未来的项目中,并扩大他作为学术讲师/研究员的知识基础。相关性:血清素转运蛋白可以说是当今临床上最相关的蛋白质。它是抗抑郁药和多种滥用药物的主要目标,并与多种心理疾病有关,包括:抑郁症、强迫症、创伤后应激障碍以及最近的自闭症。然而,我们仍然不了解 SERT 如何识别血清素和 MDMA 等底物并将其转移到神经细胞中的许多细节。了解神经系统中这一重要过程的这些方面可能会对 SERT 以及相关的去甲肾上腺素和多巴胺转运蛋白的临床靶向产生重要影响,所有这些都在我们的神经和心理健康中发挥着关键作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinctions between dopamine transporter antagonists could be just around the bend.
多巴胺转运蛋白拮抗剂之间的区别可能就在眼前。
- DOI:10.1124/mol.107.044586
- 发表时间:2008
- 期刊:
- 影响因子:3.6
- 作者:Henry,LKeith;Blakely,RandyD
- 通讯作者:Blakely,RandyD
Stereoselective inhibition of serotonin transporters by antimalarial compounds.
- DOI:10.1016/j.neuint.2013.10.009
- 发表时间:2014-07
- 期刊:
- 影响因子:4.2
- 作者:Beckman ML;Pramod AB;Perley D;Henry LK
- 通讯作者:Henry LK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loren Keith Henry其他文献
Loren Keith Henry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loren Keith Henry', 18)}}的其他基金
Computational and Biochemical Docking of Dopamine Transporter Antagonists
多巴胺转运蛋白拮抗剂的计算和生化对接
- 批准号:
8012807 - 财政年份:2010
- 资助金额:
$ 13.07万 - 项目类别:
Computational and Biochemical Docking of Dopamine Transporter Antagonists
多巴胺转运蛋白拮抗剂的计算和生化对接
- 批准号:
8212147 - 财政年份:2010
- 资助金额:
$ 13.07万 - 项目类别:
Computational and Biochemical Docking of Dopamine Transporter Antagonists
多巴胺转运蛋白拮抗剂的计算和生化对接
- 批准号:
8415923 - 财政年份:2010
- 资助金额:
$ 13.07万 - 项目类别:
Computational and Biochemical Docking of Dopamine Transporter Antagonists
多巴胺转运蛋白拮抗剂的计算和生化对接
- 批准号:
8585841 - 财政年份:2010
- 资助金额:
$ 13.07万 - 项目类别:
Integration of Computational and Biological Analysis of Serotonin Transporters
血清素转运蛋白的计算和生物学分析的整合
- 批准号:
7320103 - 财政年份:2007
- 资助金额:
$ 13.07万 - 项目类别:
Integration of Computational and Biological Analysis of Serotonin Transporters
血清素转运蛋白的计算和生物学分析的整合
- 批准号:
7588177 - 财政年份:2007
- 资助金额:
$ 13.07万 - 项目类别:
Integration of Computational and Biological Analysis of Serotonin Transporters
血清素转运蛋白的计算和生物学分析的整合
- 批准号:
7474576 - 财政年份:2007
- 资助金额:
$ 13.07万 - 项目类别:
Role of epigenetics on long-lasting behavioral and gene-expression changes following neonate exposure to antidepressants
表观遗传学对新生儿接触抗抑郁药后长期行为和基因表达变化的作用
- 批准号:
9795829 - 财政年份:
- 资助金额:
$ 13.07万 - 项目类别:
Role of epigenetics on long-lasting behavioral and gene-expression changes following neonate exposure to antidepressants
表观遗传学对新生儿接触抗抑郁药后长期行为和基因表达变化的作用
- 批准号:
9976550 - 财政年份:
- 资助金额:
$ 13.07万 - 项目类别: